Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax Is endemic

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 1, 2003, Pages 170-173

  Russell, Bruce M ^a,c   Udomsangpetch, Rachanee ^b   Rieckmann, Karl H ^a   Kotecka, Barbara M ^a   Coleman, Russell E ^c   Sattabongkot, Jetsumon ^c  

^a AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

^b MAHIDOL UNIVERSITY   (Thailand)

^c ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; DIHYDROARTEMISININ; SULFADOXINE; TAFENOQUINE;

ARTICLE; BLOOD; DRUG SENSITIVITY; ENDEMIC DISEASE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARASITE ISOLATION; PLASMODIUM VIVAX; PRIORITY JOURNAL; THAILAND; WORLD HEALTH ORGANIZATION;

ANIMALS; ANTIMALARIALS; HUMANS; MALARIA, VIVAX; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

EID: 12244307892     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.1.170-173.2003     Document Type: Article

References (13)

1. Baird, J. K., B. Leksana, S. Masbar, D. J. Fryauff, M. A. Sutanihardja Suradi, F. S. Wignall, and S. L. Hoffman. 1997. Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. Am. J. Trop. Med. Hyg. 56:621-626.
2. Bayoumi, R. A., H. A. Babiker, and D. E. Arnot. 1994. Uptake and efflux of chloroquine-resistant Plasmodium falciparum clones recently isolated in Africa. Acta Trop. 58:141-149.
3. Chotivanich, K., K. Silamut, R. Udomsangpetch, K. A. Stepniewska, S. Pukrittayakamee, S. Looareesuwam, and N. J. White. 2001. Ex-vivo short-term culture and developmental assessment of Plasmodium vivax. Trans. R. Soc. Trop. Med. Hyg. 95:677-680.
4. Findlay, G. M. 1951. Recent advances in chemotherapy, 3rd edition, vol 3. J. & A. Churchill Ltd., London, United Kingdom.
5. Imwong, M., S. Pukrittakayamee, S. Looareesuwan, G. Pasvol, J. Poirreiz, N. J. White, and G. Snounou. 2001. Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates. Antimicrob. Agents Chemother. 45:3122-3127.
6. Krogstad, D. J., I. Y. Gluzman, D. E- Kyle, A. M. J. Oduola, S. K. Martin, W. K. Milhous, and P. H. Schlesinger. 1987. Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 238:1283-1285.
7. Mendis, K., S. J. Sina, P. Marchesini, and R. Carter. 2001. The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 64:97-106.
8. Pukrittayakamee, S., A. Chantra, J. A. Simpson, S. Vanijanonta, R. Clemens, S. Looareesuwan, and N. J. White. 2000. Therapeutic responses to different antimalarial drugs in vivax malaria. Antimicrob. Agents Chemother. 44:1680-1685.
9. Rieckmanm, K. H., J. V. McNamara, H. Frischer, T. A. Stockert, P. E. Carson, R. D. Powell. 1968. Effects of chloroquine, quinine, and cycloguanil upon the maturation of asexual erythrocytic forms of two strains of Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 17:661-671.
10. Rieckmann, K. H., L. J. Sax, G. H. Campbell, and J. E. Mrema. 1978. Drug sensitivity of Plasmodium falciparum: an in vitro microtechnique. Lancet i:22-23.
11. Rieckmann, K. H., D. R. Davis, D. C. Hutton. 1989. Plasmodium vivax resistance to chloroquine? Lancet ii:1183-1184.
12. Scott, M. D., S. R. Meshnick, R. A. Williams, D. T. Chiu, H. C. Pan, B. Lubin, and F. A. Kuypers. 1989. Quighaosu-mediated oxidation in normal and abnormal erythrocytes. J. Lab. Clin. Med. 114:401-406.
13. Wellems, T. E., and C. V. Plowe. 2001. Chloroquine-resistant malaria. J. Infect. Dis. 184:770-776.